Health-Related Quality of Life Outcomes After Kidney Transplantation

Aneesha A. Shetty*, Jason A. Wertheim, Zeeshan Butt

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Citations (Scopus)

Abstract

Health-related quality of life (HRQOL) provides a measure of patients' perception of their symptoms, overall health or disability, and treatment. As such, HRQOL is an important patient-centered outcome and transplant-oriented clinical research endpoint. HRQOL alone, or in tandem with other objective clinical outcome measures, is useful in monitoring clinical practice, informing treatment decisions, and guiding the allocation of healthcare resources. It comprises three domains: physical, mental, and psychosocial wellbeing; and can be measured by generalized or targeted instruments depending on the degree of specificity desired by the clinician or researcher. Patients with end stage renal disease requiring dialysis report diminished quality of life compared to the general population, which in turn is associated with an increased risk of hospitalization and death, particularly in those with a high comorbidity burden. Renal transplantation confers a global quality of life benefit. Physical symptoms like pain, poor sleep quality, and fatigue are perceived to be improved after transplantation by renal transplant recipients with a functioning allograft. Depression and anxiety also improve after transplantation as does social participation and integration. However, on average, HRQOL following renal transplant remains lower than in the general population, partly due to transplant related complications like infection and malignancy and the adverse effects of immunosuppression. Other factors that negatively impact HRQOL after transplant include older recipient age, deceased donor transplantation, female gender, lack of social support, and comorbid conditions such as diabetes and depression. Improved HRQOL after kidney transplantation, especially in the physical domain, has been associated with better patient and allograft survival. Hence it is imperative for transplant clinicians to familiarize themselves with the concepts, measurement, and interpretation of HRQOL as they strive to provide comprehensive care to kidney transplant patients.

Original languageEnglish (US)
Title of host publicationKidney Transplantation, Bioengineering, and Regeneration
Subtitle of host publicationKidney Transplantation in the Regenerative Medicine Era
PublisherElsevier Inc
Pages699-708
Number of pages10
ISBN (Electronic)9780128018361
ISBN (Print)9780128017340
DOIs
StatePublished - Jul 6 2017

Fingerprint

Transplants
Kidney Transplantation
Quality of Life
Health
Transplantation (surgical)
Allografts
Transplantation
Depression
Social Participation
Dialysis
Kidney
Resource Allocation
Medical problems
Social Support
Immunosuppression
Population
Chronic Kidney Failure
Fatigue
Comorbidity
Sleep

Keywords

  • Immunosuppression
  • Kidney disease
  • Kidney transplantation
  • Mental health
  • Physical health
  • Quality of life
  • Social health

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Shetty, A. A., Wertheim, J. A., & Butt, Z. (2017). Health-Related Quality of Life Outcomes After Kidney Transplantation. In Kidney Transplantation, Bioengineering, and Regeneration: Kidney Transplantation in the Regenerative Medicine Era (pp. 699-708). Elsevier Inc. https://doi.org/10.1016/B978-0-12-801734-0.00050-3
Shetty, Aneesha A. ; Wertheim, Jason A. ; Butt, Zeeshan. / Health-Related Quality of Life Outcomes After Kidney Transplantation. Kidney Transplantation, Bioengineering, and Regeneration: Kidney Transplantation in the Regenerative Medicine Era. Elsevier Inc, 2017. pp. 699-708
@inbook{3ffc1c76490a48c580c7ce6637b8d528,
title = "Health-Related Quality of Life Outcomes After Kidney Transplantation",
abstract = "Health-related quality of life (HRQOL) provides a measure of patients' perception of their symptoms, overall health or disability, and treatment. As such, HRQOL is an important patient-centered outcome and transplant-oriented clinical research endpoint. HRQOL alone, or in tandem with other objective clinical outcome measures, is useful in monitoring clinical practice, informing treatment decisions, and guiding the allocation of healthcare resources. It comprises three domains: physical, mental, and psychosocial wellbeing; and can be measured by generalized or targeted instruments depending on the degree of specificity desired by the clinician or researcher. Patients with end stage renal disease requiring dialysis report diminished quality of life compared to the general population, which in turn is associated with an increased risk of hospitalization and death, particularly in those with a high comorbidity burden. Renal transplantation confers a global quality of life benefit. Physical symptoms like pain, poor sleep quality, and fatigue are perceived to be improved after transplantation by renal transplant recipients with a functioning allograft. Depression and anxiety also improve after transplantation as does social participation and integration. However, on average, HRQOL following renal transplant remains lower than in the general population, partly due to transplant related complications like infection and malignancy and the adverse effects of immunosuppression. Other factors that negatively impact HRQOL after transplant include older recipient age, deceased donor transplantation, female gender, lack of social support, and comorbid conditions such as diabetes and depression. Improved HRQOL after kidney transplantation, especially in the physical domain, has been associated with better patient and allograft survival. Hence it is imperative for transplant clinicians to familiarize themselves with the concepts, measurement, and interpretation of HRQOL as they strive to provide comprehensive care to kidney transplant patients.",
keywords = "Immunosuppression, Kidney disease, Kidney transplantation, Mental health, Physical health, Quality of life, Social health",
author = "Shetty, {Aneesha A.} and Wertheim, {Jason A.} and Zeeshan Butt",
year = "2017",
month = "7",
day = "6",
doi = "10.1016/B978-0-12-801734-0.00050-3",
language = "English (US)",
isbn = "9780128017340",
pages = "699--708",
booktitle = "Kidney Transplantation, Bioengineering, and Regeneration",
publisher = "Elsevier Inc",

}

Shetty, AA, Wertheim, JA & Butt, Z 2017, Health-Related Quality of Life Outcomes After Kidney Transplantation. in Kidney Transplantation, Bioengineering, and Regeneration: Kidney Transplantation in the Regenerative Medicine Era. Elsevier Inc, pp. 699-708. https://doi.org/10.1016/B978-0-12-801734-0.00050-3

Health-Related Quality of Life Outcomes After Kidney Transplantation. / Shetty, Aneesha A.; Wertheim, Jason A.; Butt, Zeeshan.

Kidney Transplantation, Bioengineering, and Regeneration: Kidney Transplantation in the Regenerative Medicine Era. Elsevier Inc, 2017. p. 699-708.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Health-Related Quality of Life Outcomes After Kidney Transplantation

AU - Shetty, Aneesha A.

AU - Wertheim, Jason A.

AU - Butt, Zeeshan

PY - 2017/7/6

Y1 - 2017/7/6

N2 - Health-related quality of life (HRQOL) provides a measure of patients' perception of their symptoms, overall health or disability, and treatment. As such, HRQOL is an important patient-centered outcome and transplant-oriented clinical research endpoint. HRQOL alone, or in tandem with other objective clinical outcome measures, is useful in monitoring clinical practice, informing treatment decisions, and guiding the allocation of healthcare resources. It comprises three domains: physical, mental, and psychosocial wellbeing; and can be measured by generalized or targeted instruments depending on the degree of specificity desired by the clinician or researcher. Patients with end stage renal disease requiring dialysis report diminished quality of life compared to the general population, which in turn is associated with an increased risk of hospitalization and death, particularly in those with a high comorbidity burden. Renal transplantation confers a global quality of life benefit. Physical symptoms like pain, poor sleep quality, and fatigue are perceived to be improved after transplantation by renal transplant recipients with a functioning allograft. Depression and anxiety also improve after transplantation as does social participation and integration. However, on average, HRQOL following renal transplant remains lower than in the general population, partly due to transplant related complications like infection and malignancy and the adverse effects of immunosuppression. Other factors that negatively impact HRQOL after transplant include older recipient age, deceased donor transplantation, female gender, lack of social support, and comorbid conditions such as diabetes and depression. Improved HRQOL after kidney transplantation, especially in the physical domain, has been associated with better patient and allograft survival. Hence it is imperative for transplant clinicians to familiarize themselves with the concepts, measurement, and interpretation of HRQOL as they strive to provide comprehensive care to kidney transplant patients.

AB - Health-related quality of life (HRQOL) provides a measure of patients' perception of their symptoms, overall health or disability, and treatment. As such, HRQOL is an important patient-centered outcome and transplant-oriented clinical research endpoint. HRQOL alone, or in tandem with other objective clinical outcome measures, is useful in monitoring clinical practice, informing treatment decisions, and guiding the allocation of healthcare resources. It comprises three domains: physical, mental, and psychosocial wellbeing; and can be measured by generalized or targeted instruments depending on the degree of specificity desired by the clinician or researcher. Patients with end stage renal disease requiring dialysis report diminished quality of life compared to the general population, which in turn is associated with an increased risk of hospitalization and death, particularly in those with a high comorbidity burden. Renal transplantation confers a global quality of life benefit. Physical symptoms like pain, poor sleep quality, and fatigue are perceived to be improved after transplantation by renal transplant recipients with a functioning allograft. Depression and anxiety also improve after transplantation as does social participation and integration. However, on average, HRQOL following renal transplant remains lower than in the general population, partly due to transplant related complications like infection and malignancy and the adverse effects of immunosuppression. Other factors that negatively impact HRQOL after transplant include older recipient age, deceased donor transplantation, female gender, lack of social support, and comorbid conditions such as diabetes and depression. Improved HRQOL after kidney transplantation, especially in the physical domain, has been associated with better patient and allograft survival. Hence it is imperative for transplant clinicians to familiarize themselves with the concepts, measurement, and interpretation of HRQOL as they strive to provide comprehensive care to kidney transplant patients.

KW - Immunosuppression

KW - Kidney disease

KW - Kidney transplantation

KW - Mental health

KW - Physical health

KW - Quality of life

KW - Social health

UR - http://www.scopus.com/inward/record.url?scp=85032510924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032510924&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801734-0.00050-3

DO - 10.1016/B978-0-12-801734-0.00050-3

M3 - Chapter

AN - SCOPUS:85032510924

SN - 9780128017340

SP - 699

EP - 708

BT - Kidney Transplantation, Bioengineering, and Regeneration

PB - Elsevier Inc

ER -

Shetty AA, Wertheim JA, Butt Z. Health-Related Quality of Life Outcomes After Kidney Transplantation. In Kidney Transplantation, Bioengineering, and Regeneration: Kidney Transplantation in the Regenerative Medicine Era. Elsevier Inc. 2017. p. 699-708 https://doi.org/10.1016/B978-0-12-801734-0.00050-3